LegalView Initiates Nephrogenic Systemic Fibrosis Blog to Provide Readers With Powerful Resources on the Illness

LegalView.com your source for everything legal has announced it will soon launch a Nephrogenic Systemic Fibrosis blog to further inform victims of the rare disease. Nephrogenic Systemic Fibrosis (NSF) is a rare and potentially fatal illness that is associated with those who have dealt with serious kidney disease. There are no known reported cases of the disease prior to 1997 and medical professionals are unsure as to the cause but one study showed that nearly 95 percent of those suffering from the skin disease, which also affects the internal organs, were exposed to gadolinium. Gadolinium is a chemical dye that is used in magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) tests.

LegalView will provide this and other information on its soon-to-be-launched NSF blog, which will also include updated news information dealing with Nephrogenic Systemic Fibrosis. This information can include details concerning the symptoms of the disease, which are identified through tightening and swelling of the skin usually on the extremities. This tightening and swelling of the skin occurs anywhere from several days to weeks and can often inhibit an affected victim from moving arms and legs or even debilitate them from walking. Those afflicted often complain of muscle weakness as well. LegalView's NSF blog will add to the already vast resources concerning NSF that are available through LegalView's Nephrogenic Systemic Fibrosis information (


LegalView Initiates Nephrogenic Systemic Fibrosis Blog to Provide Readers With Powerful Resources on the Illness



***Note This page is an Archieve of Publicly released information either through our company or another Press Release organization. We do not "fact check", "Support", nor "Dispute" any of the information provided to us. We are a distribution point and Historical press release research and search service. This information only represents the fact that at one point in time the release was distributed to 1000's of publications both online and off. PRNewsNow will not take sides in any personal or commercial disputes you have with the writer of this press release. We will defend its right to exist blindly and without regards to its political, commercial or personal implications.***